Practical monitoring of chronic myelogenous leukemia: when to change treatment

G Saglio, C Fava - Journal of the National Comprehensive Cancer …, 2012 - jnccn.org
In patients with chronic myelogenous leukemia (CML) treated at diagnosis with the standard
therapy consisting of imatinib, 400 mg once daily, the failure to achieve a complete …
被引用次数：11 相关文章

Practical monitoring of chronic myelogenous leukemia: when to change treatment

G Saglio, C Fava - JOURNAL OF THE NATIONAL COMPREHENSIVE …, 2012 - iris.unito.it
In patients with chronic myelogenous leukemia (CML) treated at diagnosis with the standard
therapy consisting of imatinib, 400 mg once daily, the failure to achieve a complete …

Practical Monitoring of Chronic Myelogenous Leukemia: When to Change Treatment

G Saglio, C Fava - Journal of the National Comprehensive Cancer …, 2012 - jnccn.org
In patients with chronic myelogenous leukemia (CML) treated at diagnosis with the standard
therapy consisting of imatinib, 400 mg once daily, the failure to achieve a complete …

Practical monitoring of chronic myelogenous leukemia: when to change treatment.

G Saglio, C Fava - Journal of the National Comprehensive Cancer …, 2012 - europepmc.org
In patients with chronic myelogenous leukemia (CML) treated at diagnosis with the standard
therapy consisting of imatinib, 400 mg once daily, the failure to achieve a complete …

Practical monitoring of chronic myelogenous leukemia: when to change treatment

G Saglio, C Fava - Journal of the National …, 2012 - pubmed.ncbi.nlm.nih.gov
In patients with chronic myelogenous leukemia (CML) treated at diagnosis with the standard
therapy consisting of imatinib, 400 mg once daily, the failure to achieve a complete …